| NHLBI
Research and Policy Update
Number 51
March 2008
This electronic
distribution list provides updates from the NHLBI Web Site for the
research community. The updates will be sent as needed, but no more than
once a week.
 Funding Updates
 Please
Note: Links to RFAs, PAs, and Guide Notices will take you to
the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs
will not work past their proposal receipt date. Archived versions
of RFPs posted on FEDBIZOPPS can be found on the FedBizOpps site using
the FedBizOpps
search function. Under Document to Search, simply select Archived
Documents.
RFA-HL-08-005:
Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused
Red Blood Cell Units as a Function of Preparation and Storage (R01)
| Opening
Date: |
April
21, 2008 (Earliest date an application may be submitted to Grants.gov)
|
|
Receipt
Dates: |
Letter
of Intent, April 21, 2008; December 19, 2008 |
| Application,
May 21, 2008; January 21, 2009 |
NOT-HL-08-114:
Request for Information (RFI): Public Comment on Development of a Funding
Opportunity Announcement on Translating Discoveries in the Basic Behavioral
and Social Sciences
NOT-OD-08-058:
New Frequently Asked Questions Added to OLAW Web Page
NOT-NS-08-020:
Addendum to NOT-NS-08-013 (NIH Administrative Revisions for Human
Pluripotent Stem Cell (hPSC) Research Using Non-Embryonic Sources)
NOT-HL-08-113:
NHLBI Does Not Accept R21 Applications Primarily Related to Cancer Research
NOT-OD-08-060:
Request for Information: NIH Public Access Policy
NOT-OD-08-057:
Notice of Public Meeting: Seeking Comments on Implementation of the NIH
Public Access Policy
NOT-OD-08-053:
Registration Open for the Tenth Annual NIH SBIR/STTR Conference (July
22-23, 2008)
NOT-RM-08-012:
Notice of Amendment to the Resubmission Restriction, Institutional Clinical
and Translational Science Award (U54), RFA-RM-08-002
NOT-HG-08-003:
Correction to Notice-HG-08-002, Administrative Supplements for Making
Knockout Mice
For
additional initiatives, please visit the following Web page:
NHLBI Grants and Contracts page: Funding
Opportunity Announcements (FOAs)
Policy Updates
NHLBI
Announcement: Institute to Realign its Sickle Cell Disease Research Program
Tips
for Certificate of Confidentiality Applicants
For additional
policy documents, please visit Funding /
Award Policy section on the following Web page:
Funding, Training, and Policies
Training Updates
Commitment
to New Investigators (Updated)
Guidelines
for the Applicant: Research Supplements to Promote Diversity in Health-Related
Research (Updated)
For more information
on training and career development programs, please visit the following
Web page:
Training and Career Development
Meetings
List
of upcoming meetings
Mitochondrial
Biology in Cardiovascular Health and Diseases Conference,
October 6-7, 2008
National
Heart, Lung, and Blood Advisory Council, June 11, 2008
Symposium
on Mucolipin Function in Disease, June 2-3, 2008
For more information,
and the most current list of upcoming meetings, please visit the following
Web page:
Announcements of NHLBI Meetings, Conferences,
and Events
Reports
of past meetings
The
Roles of Glycans in Hemostasis, Inflammation and Vascular Biology, NHLBI
Working Group Report, February 25-26, 2008
Circadian-Coupled
Cellular Function and Disease in Heart, Lung, and Blood, Workshop Executive
Summary, September 20, 2007
National
Heart, Lung, and Blood Advisory Council Meeting Minutes, September
12, 2007
For more
information on past meetings, please visit the following Web page:
Workshop and Meeting Summaries, and
Other Scientific Reports
Press Releases
NHLBI Media Availability: Coronary Calcium Measurement Predicts Heart
Events in Multiple Ethnic Groups, March 26, 2008
After
School Programs Can Increase Physical Activity of Adolescent Girls,
March 13, 2008
Personal
Counseling and Web-Based Strategies Show Modest Success for Sustaining
Weight Loss, According to NHLBI Study, March 11, 2008
NHLBI
Announcement: Institute to Realign its Sickle Cell Disease Research Program,
March 10, 2008
Researchers
Identify Genetic Variation to Predict Initial Response to Commonly Prescribed
Blood Thinning Drug, March 5, 2008
WHI
Follow-up Study Confirms Health Risks of Long-Term Combination Hormone
Therapy Outweigh Benefits for Postmenopausal Women, March 4, 2008
NHLBI
Issues First U.S. von Willebrand Disease Clinical Practice Guidelines,
February 29, 2008
For additional
Press Releases, please visit the NHLBI
News Room
Selected NHLBI Vacancies
To
receive bi-weekly e-updates about NHLBI job opportunities, please e-mail
your request to Marianna Mertts, PhD, Office of Workforce Management.
(Links
to announcements will not work past their closing date.)
| Position Title |
Location |
Salary and Grade
|
Closing
Date |
| Bethesda, MD |
$82,961 - $127,442
GS-0602-13/14 |
May 10, 2008 |
| Bethesda, MD |
$115,317 - $149,000
GS-0602-15/15 |
May 10, 2008 |
| Bethesda, MD |
$82,961 - $127,442
GS-0602-13/14 |
May 10, 2008 |
| Bethesda, MD |
$115,317 - $149,000
GS-0602-15/15 |
May 10, 2008 |
Bethesda, MD |
$82,961 - $127,442
HSA: GS-0601-13/14
Med. Officer: GS-0602-13/14 |
April 4, 2008 |
| Bethesda, MD |
$69,764 - $127,442
GS-0601-12/14 |
March 31, 2008 |
| Bethesda, MD |
$98,033 - $149,000
GS-0602-14/15 |
March 28, 2008 |
Bethesda, MD |
$115,317 - $149,000
HSA: GS-0601-15/15
Med. Officer: GS-0602-15/15 |
March 28, 2008
|
Note: There
are often changes and additions to the selected vacancy list. For the
most current information, please visit the NHLBI
Jobs Opportunities page
Other Items of Interest
New
Limited Access Datasets:
The
Retrovirus Epidemiology Donor Study HTLV Cohort (REDS). This project
conducted a longitudinal, multicenter epidemiologic study of the human
retroviruses HIV-1, HIV-2, HTLV-I, and HTLV-II in volunteer blood donors
from areas of the United States that were reportedly at high and medium
or low risk for HIV.
Multi-Ethnic
Study of Atherosclerosis (MESA).
This project investigated the prevalence, correlates, and progression
of subclinical CVD and risk factors that predict progression to clinically
overt CVD, and that predict progression of subclinical disease itself,
in a population-based sample of 6,800 ethnically diverse men and women.
Prevention
of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial.
This project conducted a trial to test the hypothesis that patients with
stable coronary artery disease and normal or slightly reduced left ventricular
function derive therapeutic benefit from the addition of ACE inhibitors
to modern conventional therapy.
An
Archive of the current and past issues
is available on the NHLBI Web site.
Two
ways to unsubscribe:
- Send an e-mail message to: LISTSERV@LIST.NIH.GOV
and, in the text of your message (not the subject line), write
(or copy/paste):
SIGNOFF NHLBI-RESEARCH-POLICY-L
- Use the List Web Page
A) select
this link
B) Enter your e-mail address as it appears in the To: field
of the list,
C) Enter your full name, and
D) Select the button, Leave the list.
|
